Diphtheria, Pertussis, and Tetanus Vaccine Market, Global Outlook and Forecast 2022-2028
Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.
This report contains market size and forecasts of Diphtheria, Pertussis, and Tetanus Vaccine in global, including the following market information:
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Diphtheria, Pertussis, and Tetanus Vaccine companies in 2021 (%)
The global Diphtheria, Pertussis, and Tetanus Vaccine market was valued at 2595 million in 2021 and is projected to reach US$ 3344.2 million by 2028, at a CAGR of 3.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DTaP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine include Johnson & Johnson, GlaxoSmithKline, Sanofi, Lanzhou Institute of Biological, Merck, Novartis, AstraZeneca, Emergent and Astellas. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diphtheria, Pertussis, and Tetanus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diphtheria, Pertussis, and Tetanus Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Diphtheria, Pertussis, and Tetanus Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diphtheria, Pertussis, and Tetanus Vaccine revenues share in global market, 2021 (%)
Key companies Diphtheria, Pertussis, and Tetanus Vaccine sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Diphtheria, Pertussis, and Tetanus Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Diphtheria, Pertussis, and Tetanus Vaccine in global, including the following market information:
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Diphtheria, Pertussis, and Tetanus Vaccine companies in 2021 (%)
The global Diphtheria, Pertussis, and Tetanus Vaccine market was valued at 2595 million in 2021 and is projected to reach US$ 3344.2 million by 2028, at a CAGR of 3.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DTaP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine include Johnson & Johnson, GlaxoSmithKline, Sanofi, Lanzhou Institute of Biological, Merck, Novartis, AstraZeneca, Emergent and Astellas. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diphtheria, Pertussis, and Tetanus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diphtheria, Pertussis, and Tetanus Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Segment Percentages, by Type, 2021 (%)
- DTaP
- Td
- Tdap
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Vaccination Centers
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Diphtheria, Pertussis, and Tetanus Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diphtheria, Pertussis, and Tetanus Vaccine revenues share in global market, 2021 (%)
Key companies Diphtheria, Pertussis, and Tetanus Vaccine sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Diphtheria, Pertussis, and Tetanus Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- GlaxoSmithKline
- Sanofi
- Lanzhou Institute of Biological
- Merck
- Novartis
- AstraZeneca
- Emergent
- Astellas
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE OVERALL MARKET SIZE
2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size: 2021 VS 2028
2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Diphtheria, Pertussis, and Tetanus Vaccine Players in Global Market
3.2 Top Global Diphtheria, Pertussis, and Tetanus Vaccine Companies Ranked by Revenue
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Companies
3.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Companies
3.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Diphtheria, Pertussis, and Tetanus Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Diphtheria, Pertussis, and Tetanus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Markets, 2021 & 2028
4.1.2 DTaP
4.1.3 Td
4.1.4 Tdap
4.2 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts
4.2.1 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts
4.3.1 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2022
4.3.2 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2023-2028
4.3.3 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Vaccination Centers
5.2 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts
5.2.1 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts
5.3.1 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2022
5.3.2 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2023-2028
5.3.3 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts
6.2.1 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts
6.3.1 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2022
6.3.2 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2023-2028
6.3.3 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.4.3 US Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.4.4 Canada Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.4.5 Mexico Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.5.3 Germany Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.4 France Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.5 U.K. Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.6 Italy Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.7 Russia Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.9 Benelux Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.6.3 China Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.4 Japan Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.5 South Korea Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.7 India Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.7.3 Brazil Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.7.4 Argentina Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.8.3 Turkey Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8.4 Israel Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8.6 UAE Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Lanzhou Institute of Biological
7.4.1 Lanzhou Institute of Biological Corporate Summary
7.4.2 Lanzhou Institute of Biological Business Overview
7.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Lanzhou Institute of Biological Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Merck Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Novartis Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 AstraZeneca Key News
7.8 Emergent
7.8.1 Emergent Corporate Summary
7.8.2 Emergent Business Overview
7.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Emergent Key News
7.9 Astellas
7.9.1 Astellas Corporate Summary
7.9.2 Astellas Business Overview
7.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Astellas Key News
8 GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, 2017-2028
8.2 Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE SUPPLY CHAIN ANALYSIS
10.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Value Chain
10.2 Diphtheria, Pertussis, and Tetanus Vaccine Upstream Market
10.3 Diphtheria, Pertussis, and Tetanus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE OVERALL MARKET SIZE
2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size: 2021 VS 2028
2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Diphtheria, Pertussis, and Tetanus Vaccine Players in Global Market
3.2 Top Global Diphtheria, Pertussis, and Tetanus Vaccine Companies Ranked by Revenue
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Companies
3.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Companies
3.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Diphtheria, Pertussis, and Tetanus Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Diphtheria, Pertussis, and Tetanus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Markets, 2021 & 2028
4.1.2 DTaP
4.1.3 Td
4.1.4 Tdap
4.2 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts
4.2.1 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts
4.3.1 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2022
4.3.2 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2023-2028
4.3.3 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Vaccination Centers
5.2 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts
5.2.1 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts
5.3.1 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2022
5.3.2 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2023-2028
5.3.3 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue & Forecasts
6.2.1 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales & Forecasts
6.3.1 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2022
6.3.2 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2023-2028
6.3.3 By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.4.3 US Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.4.4 Canada Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.4.5 Mexico Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.5.3 Germany Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.4 France Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.5 U.K. Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.6 Italy Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.7 Russia Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.5.9 Benelux Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.6.3 China Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.4 Japan Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.5 South Korea Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.6.7 India Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.7.3 Brazil Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.7.4 Argentina Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, 2017-2028
6.8.3 Turkey Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8.4 Israel Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
6.8.6 UAE Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Lanzhou Institute of Biological
7.4.1 Lanzhou Institute of Biological Corporate Summary
7.4.2 Lanzhou Institute of Biological Business Overview
7.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Lanzhou Institute of Biological Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Merck Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Novartis Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 AstraZeneca Key News
7.8 Emergent
7.8.1 Emergent Corporate Summary
7.8.2 Emergent Business Overview
7.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Emergent Key News
7.9 Astellas
7.9.1 Astellas Corporate Summary
7.9.2 Astellas Business Overview
7.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Major Product Offerings
7.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Astellas Key News
8 GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, 2017-2028
8.2 Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE SUPPLY CHAIN ANALYSIS
10.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Value Chain
10.2 Diphtheria, Pertussis, and Tetanus Vaccine Upstream Market
10.3 Diphtheria, Pertussis, and Tetanus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Diphtheria, Pertussis, and Tetanus Vaccine in Global Market
Table 2. Top Diphtheria, Pertussis, and Tetanus Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Companies, (K MT), 2017-2022
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type
Table 9. List of Global Tier 1 Diphtheria, Pertussis, and Tetanus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2017-2022
Table 15. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2023-2028
Table 16. By Application – Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2017-2022
Table 20. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2023-2028
Table 21. By Region – Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2017-2022
Table 25. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2023-2028
Table 26. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 29. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 30. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 33. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 34. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 37. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 38. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 41. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 48. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 51. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 54. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Lanzhou Institute of Biological Corporate Summary
Table 56. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 57. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Merck Corporate Summary
Table 59. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 60. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Novartis Corporate Summary
Table 62. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 63. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. AstraZeneca Corporate Summary
Table 65. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 66. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Emergent Corporate Summary
Table 68. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 69. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Astellas Corporate Summary
Table 71. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 72. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 74. Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region, 2017-2022 (K MT)
Table 76. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region, 2023-2028 (K MT)
Table 77. Diphtheria, Pertussis, and Tetanus Vaccine Market Opportunities & Trends in Global Market
Table 78. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers in Global Market
Table 79. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints in Global Market
Table 80. Diphtheria, Pertussis, and Tetanus Vaccine Raw Materials
Table 81. Diphtheria, Pertussis, and Tetanus Vaccine Raw Materials Suppliers in Global Market
Table 82. Typical Diphtheria, Pertussis, and Tetanus Vaccine Downstream
Table 83. Diphtheria, Pertussis, and Tetanus Vaccine Downstream Clients in Global Market
Table 84. Diphtheria, Pertussis, and Tetanus Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Diphtheria, Pertussis, and Tetanus Vaccine in Global Market
Table 2. Top Diphtheria, Pertussis, and Tetanus Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Companies, (K MT), 2017-2022
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type
Table 9. List of Global Tier 1 Diphtheria, Pertussis, and Tetanus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diphtheria, Pertussis, and Tetanus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2017-2022
Table 15. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2023-2028
Table 16. By Application – Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2017-2022
Table 20. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2023-2028
Table 21. By Region – Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2017-2022
Table 25. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), 2023-2028
Table 26. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 29. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 30. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 33. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 34. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 37. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 38. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 41. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales, (K MT), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 48. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 51. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 54. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Lanzhou Institute of Biological Corporate Summary
Table 56. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 57. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Merck Corporate Summary
Table 59. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 60. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Novartis Corporate Summary
Table 62. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 63. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. AstraZeneca Corporate Summary
Table 65. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 66. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Emergent Corporate Summary
Table 68. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 69. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Astellas Corporate Summary
Table 71. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Offerings
Table 72. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 74. Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region, 2017-2022 (K MT)
Table 76. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region, 2023-2028 (K MT)
Table 77. Diphtheria, Pertussis, and Tetanus Vaccine Market Opportunities & Trends in Global Market
Table 78. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers in Global Market
Table 79. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints in Global Market
Table 80. Diphtheria, Pertussis, and Tetanus Vaccine Raw Materials
Table 81. Diphtheria, Pertussis, and Tetanus Vaccine Raw Materials Suppliers in Global Market
Table 82. Typical Diphtheria, Pertussis, and Tetanus Vaccine Downstream
Table 83. Diphtheria, Pertussis, and Tetanus Vaccine Downstream Clients in Global Market
Table 84. Diphtheria, Pertussis, and Tetanus Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type
Figure 2. Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application
Figure 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Diphtheria, Pertussis, and Tetanus Vaccine Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2021
Figure 9. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/MT), 2017-2028
Figure 12. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/MT), 2017-2028
Figure 15. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 19. US Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 33. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Diphtheria, Pertussis, and Tetanus Vaccine by Region, 2021 VS 2028
Figure 50. Diphtheria, Pertussis, and Tetanus Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type
Figure 2. Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application
Figure 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Diphtheria, Pertussis, and Tetanus Vaccine Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2021
Figure 9. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/MT), 2017-2028
Figure 12. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/MT), 2017-2028
Figure 15. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 19. US Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 33. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Diphtheria, Pertussis, and Tetanus Vaccine by Region, 2021 VS 2028
Figure 50. Diphtheria, Pertussis, and Tetanus Vaccine Industry Value Chain
Figure 51. Marketing Channels
